rAAV-based and intraprostatically delivered miR-34a therapeutics for efficient inhibition of prostate cancer progression

Gene Therapy, Published online: 06 July 2021; doi:10.1038/s41434-021-00275-5rAAV-based and intraprostatically delivered miR-34a therapeutics for efficient inhibition of prostate cancer progression

https://www.nature.com/articles/s41434-021-00275-5

Source: Gene Therapy - July 6, 2021 Category: Genetics & Stem Cells Authors: Jianzhong Ai Jia Li Qin Su Hong Ma Ran He Qiang Wei Hong Li Guangping Gao Source Type: research

More News: Cancer | Cancer & Oncology | Gene Therapy | Genetics | Prostate Cancer